LQDA Liquidia Corp
8-K Current Report
Filed: March 5, 2026
Health Care
Pharmaceutical PreparationsLiquidia Corp (LQDA) 8-K current report filed with SEC EDGAR on March 5, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Q4 or full-year 2025 earnings results disclosed via press release exhibit, signed March 5, 2026
- • Full financial details in the accompanying exhibit — no key figures included in the 8-K body text
Get deeper insights on Liquidia Corp
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.